Dual Listed Biotech Begins to Prepare POC Preclinical Study for Diabetes & Obesity Dual Gene Therapy Program
04 Dicembre 2023 - 2:00PM
AllPennyStocks.com
Obesity and diabetes have become a problem for developed world
countries. To address the global rise of these issues, this company
is pursuing a dual-gene therapy strategy using
proprietary...
To read the full story on AllPennyStocks.com, click
here.
Grafico Azioni PreveCeutical Medical (CSE:PREV)
Storico
Da Gen 2025 a Feb 2025
Grafico Azioni PreveCeutical Medical (CSE:PREV)
Storico
Da Feb 2024 a Feb 2025
Notizie in Tempo Reale relative a PreveCeutical Medical Inc (Canadian Securities Exchange): 0 articoli recenti
Più PreveCeutical Medical Inc Articoli Notizie